Drug-resistance or viral load testing required before switch to dolutegravir in Togo
Dolutegravir-based antiretroviral treatment (ART) in combination with an NRTI backbone will not be effective in Togo, due to high levels of resistance to the NRTI class of drugs, according to a study presented by Professor Mounerou Salou of the Laboratoire Biolim in Togo at the recent 20th International Conference on AIDS and STIs in Africa (ICASA)… Read More »